RETRACTED ARTICLE: Discovery of (<i>E</i>)-<i>N</i>-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug.

Chem Zvesti · 2021 · PMC8126404 · PMID 34025012

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

effectively significantno p-value reported

If cyanorona-20 passes the in vivo bioassays and preclinical/clinical trials with effectively significant results as anti-COVID-19 agent, combination therapy with a second potent antiviral drug, such as remdesivir, may also be advantageous.

also in 21 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.